HomeCompareHCMPX vs JNJ

HCMPX vs JNJ: Dividend Comparison 2026

HCMPX yields 0.45% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HCMPX wins by $284.00 in total portfolio value
10 years
HCMPX
HCMPX
● Live price
0.45%
Share price
$19.54
Annual div
$0.09
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$46.65
Full HCMPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HCMPX vs JNJ

📍 HCMPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHCMPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HCMPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HCMPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HCMPX
Annual income on $10K today (after 15% tax)
$38.50/yr
After 10yr DRIP, annual income (after tax)
$39.65/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $663.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HCMPX + JNJ for your $10,000?

HCMPX: 50%JNJ: 50%
100% JNJ50/50100% HCMPX
Portfolio after 10yr
$20.2K
Annual income
$437.21/yr
Blended yield
2.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HCMPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HCMPX buys
0
JNJ buys
0
No recent congressional trades found for HCMPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHCMPXJNJ
Forward yield0.45%3.36%
Annual dividend / share$0.09$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.3K$20.0K
Annual income after 10y$46.65$827.78
Total dividends collected$460.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HCMPX vs JNJ ($10,000, DRIP)

YearHCMPX PortfolioHCMPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,745$45.29$10,676$355.77+$69.00HCMPX
2$11,543$45.48$11,407$389.39+$136.00HCMPX
3$12,397$45.66$12,198$426.53+$199.00HCMPX
4$13,310$45.83$13,056$467.62+$254.00HCMPX
5$14,288$45.99$13,987$513.12+$301.00HCMPX
6$15,334$46.14$14,998$563.56+$336.00HCMPX
7$16,454$46.28$16,098$619.52+$356.00HCMPX
8$17,652$46.41$17,295$681.69+$357.00HCMPX
9$18,934$46.53$18,599$750.82+$335.00HCMPX
10$20,306$46.65$20,022$827.78+$284.00HCMPX

HCMPX vs JNJ: Complete Analysis 2026

HCMPXStock

The fund seeks to achieve its investment objective through investments in (i) dividend paying equity securities of companies included in the S&P 500; (ii) plus other investment companies (mutual funds, closed-end funds and ETFs), including investment companies that use leverage; and (iii) cash and cash equivalents and put and call options. The fund is designed to maximize returns through investing in any combination of sectors, asset classes, and sub-sectors as determined by the HCM-BuyLine®.

Full HCMPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HCMPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HCMPX vs SCHDHCMPX vs JEPIHCMPX vs OHCMPX vs KOHCMPX vs MAINHCMPX vs ABBVHCMPX vs MRKHCMPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.